Rice Hall James & Associates LLC cut its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 7.4% in the 1st quarter, Holdings Channel.com reports. The firm owned 887,126 shares of the biopharmaceutical company’s stock after selling 70,562 shares during the quarter. ACADIA Pharmaceuticals comprises 0.9% of Rice Hall James & Associates LLC’s holdings, […]